These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 9540190)

  • 1. [Combined sabal and urtica extract vs. finasteride in benign prostatic hyperplasia (Alken stages I to II). Comment on the contribution by J. Sokeland and J. Albrech].
    Bartsch G; Dreikom K; Schöntöger PS
    Urologe A; 1998 Jan; 37(1):83-5. PubMed ID: 9540190
    [No Abstract]   [Full Text] [Related]  

  • 2. [Combination of Sabal and Urtica extract vs. finasteride in benign prostatic hyperplasia (Aiken stages I to II). Comparison of therapeutic effectiveness in a one year double-blind study].
    Sökeland J; Albrecht J
    Urologe A; 1997 Jul; 36(4):327-33. PubMed ID: 9340898
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Combined sabal and urtica extract compared with finasteride in men with benign prostatic hyperplasia: analysis of prostate volume and therapeutic outcome.
    Sökeland J
    BJU Int; 2000 Sep; 86(4):439-42. PubMed ID: 10971268
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Efficacy of a combined Sabal-urtica preparation in the symptomatic treatment of benign prostatic hyperplasia. Results of a placebo-controlled double-blind study].
    Popa G; Hägele-Kaddour H; Walther C
    MMW Fortschr Med; 2005 Oct; 147 Suppl 3():103-8. PubMed ID: 16261945
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Drug therapy of benign prostatic hyperplasia].
    Vahlensieck W; Fabricius PG; Hell U
    Fortschr Med; 1996 Nov; 114(31):407-11. PubMed ID: 9036092
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Benign prostatic syndrome. Urinary urgency and micturition frequency reduced with plant preparation].
    MMW Fortschr Med; 2005 Oct; 147(40):52-3. PubMed ID: 16255520
    [No Abstract]   [Full Text] [Related]  

  • 7. Evaluation of male sexual function in patients with Lower Urinary Tract Symptoms (LUTS) associated with Benign Prostatic Hyperplasia (BPH) treated with a phytotherapeutic agent (Permixon), Tamsulosin or Finasteride.
    Zlotta AR; Teillac P; Raynaud JP; Schulman CC
    Eur Urol; 2005 Aug; 48(2):269-76. PubMed ID: 15939527
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Drugs for the treatment of benign prostatic hypertrophy].
    Caprino L
    Minerva Urol Nefrol; 2000 Jun; 52(2):87-92. PubMed ID: 11085067
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Urodynamic effects of finasteride in the treatment of bladder outlet obstruction due to benign prostatic hyperplasia.
    Tammela TL; Kontturi MJ
    J Urol; 1993 Feb; 149(2):342-4. PubMed ID: 7678871
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The efficacy of terazosin, finasteride, or both in benign prostatic hyperplasia. Veterans Affairs Cooperative Studies Benign Prostatic Hyperplasia Study Group.
    Lepor H; Williford WO; Barry MJ; Brawer MK; Dixon CM; Gormley G; Haakenson C; Machi M; Narayan P; Padley RJ
    N Engl J Med; 1996 Aug; 335(8):533-9. PubMed ID: 8684407
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sabal serrulata extract (Strogen forte) in the treatment of symptomatic benign prostatic hyperplasia.
    Kondás J; Philipp V; Diószeghy G
    Int Urol Nephrol; 1996; 28(6):767-72. PubMed ID: 9089044
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Saw palmetto extracts for benign prostatic hyperplasia.
    Segars LW
    J Fam Pract; 1999 Feb; 48(2):88-9. PubMed ID: 10037530
    [No Abstract]   [Full Text] [Related]  

  • 13. Continued improvement in pressure-flow parameters in men receiving finasteride for 2 years. Finasteride Urodynamics Study Group.
    Schäfer W; Tammela TL; Barrett DM; Abrams P; Hedlund H; Rollema HJ; Nordling J; Andersen JT; Hald T; Matos-Ferriera A; Bruskewitz R; Miller P; Mustonen S; Cannon A; Malice MP; Jacobsen CA; Bach MA
    Urology; 1999 Aug; 54(2):278-83. PubMed ID: 10443725
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comment on the appropriateness of The Prostate publishing a trial comparing Permixon to finasteride without a placebo control group.
    Gillenwater JY
    Prostate; 1998 Nov; 37(3):194. PubMed ID: 9792137
    [No Abstract]   [Full Text] [Related]  

  • 15. [Two drugs have a better outcome. Finasteride plus alpha blocker improves urine flow].
    MMW Fortschr Med; 2003 Nov; 145(47):62. PubMed ID: 14725041
    [No Abstract]   [Full Text] [Related]  

  • 16. Pharmacologic therapy for prostatism.
    Lieber MM
    Mayo Clin Proc; 1998 Jun; 73(6):590-6. PubMed ID: 9621869
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Prostaplant treatment of benign prostatic hyperplasia].
    Medvedev AA; Siniakova LA; Zaĭtsev AV
    Urologiia; 2000; (4):13-5. PubMed ID: 11186685
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Significance of 5-alpha-reductase inhibitors in therapy of benign prostatic hyperplasia with mild to modern symptoms].
    Wirth MP; Helke C; Froschermaier SE
    Urologe A; 1997 Jan; 36(1):35-9. PubMed ID: 9123679
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [5-alpha-reductase inhibitors in benign prostatic hyperplasia].
    Panchev P; Neĭkov K
    Khirurgiia (Sofiia); 1997; 50(1):41-3. PubMed ID: 9379618
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effect of doxazosin, finasteride and combination therapy on nocturia in men with benign prostatic hyperplasia.
    Johnson TM; Burrows PK; Kusek JW; Nyberg LM; Tenover JL; Lepor H; Roehrborn CG;
    J Urol; 2007 Nov; 178(5):2045-50; discussion 2050-1. PubMed ID: 17869295
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.